Masimo (MASI) Cash & Equivalents Growth (3y) (2012 - 2026)
Masimo (MASI) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.99% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.52% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -0.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 16.75% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.11% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -10.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -10.55% |
| Jan 3, 2026 | -9.12% |
| Sep 27, 2025 | 12.47% |
| Jun 28, 2025 | -11.80% |
| Mar 29, 2025 | -61.47% |
| Dec 28, 2024 | -45.06% |
| Sep 28, 2024 | -43.60% |
| Jun 29, 2024 | -60.17% |
| Mar 30, 2024 | -40.19% |
| Dec 30, 2023 | -42.68% |
| Sep 30, 2023 | -42.92% |
| Jul 1, 2023 | -37.99% |
| Apr 1, 2023 | -34.01% |
| Dec 31, 2022 | -29.03% |
| Oct 1, 2022 | -24.66% |
| Jul 2, 2022 | -18.91% |
| Apr 2, 2022 | 20.37% |
| Jan 1, 2022 | 10.49% |
| Oct 2, 2021 | 9.75% |
| Jul 3, 2021 | 10.26% |